Clinical Trials
To fulfill Dr. Miller’s passion for clinical research, Advanced Neurology of Colorado has a research counterpart, Advanced Neurosciences Research, LLC. Currently the research team runs over 20 clinical trials, including those listed below, which are the clinical trials that are currently enrolling participants. For more information, please visit http://www.clinicaltrials.gov
Serono 28821, ORACLE: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS.Teva PM080, OCTAGON: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of Glatiramer Acetate on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients with a First Episode of Acute Optic Neuritis.Biogen 109MS325, SURPASS: Multicenter, Randomized, Rater-Blind, Parallel-Group, Active-Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon -1a) to Natalizumab in Subjects With Relapsing Remitting Multiple Sclerosis.ONO-4641 POU00006: A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis.
|
